Gene: GUCY1A2

2977
GC-SA2|GUC1A2
guanylate cyclase 1 soluble subunit alpha 2
protein-coding
11q22.3
Ensembl:ENSG00000152402 MIM:601244 Vega:OTTHUMG00000166296 UniprotKB:P33402
NC_000011.10
SNP Mapped
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
9.301e-1 (AD)  1.220e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs10890597chr11:106804584 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
FAM126B0.939
CACNB40.939
CHM0.935
GABRA40.934
CSRNP30.933
SLC2A130.933
SACS0.931
FRRS1L0.93
PTPN40.928
CHIC10.923

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CSAG1-0.52
FLT3LG-0.484
HEY2-0.475
MYL3-0.473
COPZ2-0.47
RAB13-0.468
ROM1-0.455
AGTRAP-0.452
EMP3-0.447
RHOD-0.44

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00435Nitric OxideSmall Molecule10102-43-9ApprovedTarget
DB01020Isosorbide MononitrateSmall Molecule16051-77-7ApprovedTarget
DB08931RiociguatSmall Molecule625115-55-1ApprovedTarget
DB09241Methylene blueSmall Molecule61-73-4Approved|InvestigationalTarget
DB09282MolsidomineSmall Molecule25717-80-0Approved|InvestigationalTarget
DB13170PlecanatideSmall Molecule467426-54-6Approved|InvestigationalTarget
DB09282MolsidomineSmall Molecule25717-80-0Approved|InvestigationalEnzyme
ID Drug Name Action PubMed
C0264861,2,5,6-dibenzanthracene"1,2,5,6-dibenzanthracene results in increased expression of GUCY1A2 mRNA"26377693
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GUCY1A2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GUCY1A2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GUCY1A2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GUCY1A2 mRNA"27188386
D000638AmiodaroneAmiodarone results in increased expression of GUCY1A2 mRNA19774075
D000643Ammonium ChlorideAmmonium Chloride affects the expression of GUCY1A2 mRNA16483693
D001104ArbutinArbutin results in decreased expression of GUCY1A2 mRNA17103032
C547126AZM551248AZM551248 results in decreased expression of GUCY1A2 mRNA22323515
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of GUCY1A2 mRNA17879257
C006780bisphenol Abisphenol A results in decreased expression of GUCY1A2 mRNA25181051
C006780bisphenol Abisphenol A results in increased expression of GUCY1A2 mRNA29097150
C018475butyraldehydebutyraldehyde results in decreased expression of GUCY1A2 mRNA26079696
D019256Cadmium ChlorideCadmium Chloride results in decreased methylation of GUCY1A2 promoter22457795
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GUCY1A2 mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in decreased expression of GUCY1A2 mRNA26272509
D003471CuprizoneCuprizone results in decreased expression of GUCY1A2 mRNA26577399
C010902decabromobiphenyl etherdecabromobiphenyl ether results in decreased expression of GUCY1A2 mRNA23640034
C118739entinostatentinostat results in decreased expression of GUCY1A2 mRNA27188386
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of GUCY1A2 mRNA29097150
D005419FlavonoidsFlavonoids results in increased expression of GUCY1A2 mRNA18035473
D004397FonofosFonofos results in increased methylation of GUCY1A2 promoter22847954
D006152Cyclic GMP[[GUCY1A2 protein binds to GUCY1B1 protein] which results in increased metabolism of Guanosine Triphosphate] which results in increased chemical synthesis of Cyclic GMP19895661
D006160Guanosine Triphosphate[GUCY1A2 protein binds to GUCY1B1 protein] which results in increased metabolism of Guanosine Triphosphate19895661
D006160Guanosine Triphosphate[[GUCY1A2 protein binds to GUCY1B1 protein] which results in increased metabolism of Guanosine Triphosphate] which results in increased chemical synthesis of Cyclic GMP19895661
C011890kojic acidkojic acid results in decreased expression of GUCY1A2 mRNA16595896
D007854LeadLead affects the expression of GUCY1A2 mRNA28903495
C004925methylmercuric chloridemethylmercuric chloride affects the expression of GUCY1A2 protein27012723
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of GUCY1A2 mRNA"25554681|2562005
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of GUCY1A2 mRNA"25554681
D009532NickelNickel results in decreased expression of GUCY1A2 mRNA24768652|2558310
D009569Nitric OxideNitric Oxide binds to and results in increased activity of [GUCY1A2 protein binds to GUCY1B1 protein]19895661
D010278ParathionParathion results in increased methylation of GUCY1A2 promoter22847954
C101814perfluoro-n-undecanoic acidperfluoro-n-undecanoic acid results in increased expression of GUCY1A2 mRNA23602845
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GUCY1A2 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of GUCY1A2 mRNA26272509
D010936Plant ExtractsPlant Extracts results in decreased expression of GUCY1A2 mRNA23557933
D011441PropylthiouracilPropylthiouracil results in decreased expression of GUCY1A2 mRNA24780913
D012822Silicon DioxideSilicon Dioxide analog results in increased expression of GUCY1A2 mRNA23806026
D053260SootSoot results in decreased expression of GUCY1A2 mRNA26551751
C012568terbufosterbufos results in increased methylation of GUCY1A2 promoter22847954
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of GUCY1A2 mRNA21570461
D014241TrichloroethyleneTrichloroethylene results in decreased methylation of GUCY1A2 gene27618143
C012589trichostatin Atrichostatin A results in decreased expression of GUCY1A2 mRNA28542535
D014635Valproic AcidValproic Acid results in decreased expression of GUCY1A2 mRNA27188386
D014635Valproic AcidValproic Acid results in increased expression of GUCY1A2 mRNA28001369

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005515protein binding-IPI24550280  
GO:0005525GTP binding-IEA-  
GO:0020037heme binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0007165signal transduction-TAS1683630  
GO:0035556intracellular signal transduction-IEA-  
GO ID GO Term Qualifier Evidence PubMed
KEGG ID KEGG Term
hsa00230Purine metabolism
hsa04270Vascular smooth muscle contraction
hsa04540Gap junction
hsa04730Long-term depression
hsa04970Salivary secretion
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisIEA
R-HSA-392154Nitric oxide stimulates guanylate cyclaseIEA
R-HSA-418346Platelet homeostasisIEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal